Cargando…
Ilamycin C induces apoptosis and inhibits migration and invasion in triple-negative breast cancer by suppressing IL-6/STAT3 pathway
BACKGROUND: Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer with poor prognosis, and its treatment remains a challenge due to few targeted medicines and high risk of relapse, metastasis, and drug resistance. Thus, more effective drugs and new regimens for the the...
Autores principales: | Xie, Qing, Yang, Zhijie, Huang, Xuanmei, Zhang, Zikang, Li, Jiangbin, Ju, Jianhua, Zhang, Hua, Ma, Junying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558915/ https://www.ncbi.nlm.nih.gov/pubmed/31186039 http://dx.doi.org/10.1186/s13045-019-0744-3 |
Ejemplares similares
-
Characterization of Regulatory and Transporter Genes in the Biosynthesis of Anti-Tuberculosis Ilamycins and Production in a Heterologous Host
por: He, Jianqiao, et al.
Publicado: (2020) -
Semi-Synthesis of Marine-Derived Ilamycin F Derivatives and Their Antitubercular Activities
por: Li, Jun, et al.
Publicado: (2021) -
Ilamycin E, a natural product of marine actinomycete, inhibits triple-negative breast cancer partially through ER stress-CHOP-Bcl-2
por: Zhou, Wenhui, et al.
Publicado: (2019) -
Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents
por: Ma, Junying, et al.
Publicado: (2017) -
Total Synthesis and Biological Evaluation of Modified Ilamycin Derivatives
por: Greve, Jennifer, et al.
Publicado: (2022)